Cargando…

Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model

Currently authorized COVID-19 vaccines induce humoral and cellular responses to epitopes in the SARS-CoV-2 spike protein, though the relative roles of antibodies and T cells in protection are not well understood. To understand the role of vaccine-elicited T cell responses in protection, we establish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tada, Takuya, Peng, Ju-Yi, Dcosta, Belinda M., Landau, Nathaniel R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132166/ https://www.ncbi.nlm.nih.gov/pubmed/37036004 http://dx.doi.org/10.1172/jci.insight.167306

Ejemplares similares

Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model
por: Tada, Takuya, et al.
Publicado: (2023)

Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies
por: Zhou, Hao, et al.
Publicado: (2022)

Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
por: Tada, Takuya, et al.
Publicado: (2021)

B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies
por: Zhou, Hao, et al.
Publicado: (2021)

Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model
por: Tada, Takuya, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies
por: Tada, Takuya, et al.
Publicado: (2022)

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes
por: Tada, Takuya, et al.
Publicado: (2021)

High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals
por: Tada, Takuya, et al.
Publicado: (2022)

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
por: Tada, Takuya, et al.
Publicado: (2022)

An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
por: Tada, Takuya, et al.
Publicado: (2020)

Directly injected lentiviral vector–based T cell vaccine protects mice against acute and chronic viral infection
por: Tada, Takuya, et al.
Publicado: (2022)

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
por: Ku, Min-Wen, et al.
Publicado: (2021)

Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4)
por: Kaur, Ramanjit, et al.
Publicado: (2023)

Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions
por: Christie, Shaun M., et al.
Publicado: (2022)

Development of Inactivated FAKHRAVAC(®) Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
por: Ghasemi, Soheil, et al.
Publicado: (2021)

Engineered multivalent self-assembled binder protein against SARS-CoV-2 RBD
por: Britton, Dustin, et al.
Publicado: (2022)

Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection
por: Pitaloka, Dian Ayu Eka, et al.
Publicado: (2022)

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens
por: Counoupas, Claudio, et al.
Publicado: (2022)

A candidate multi-epitope vaccine against SARS-CoV-2
por: Kar, Tamalika, et al.
Publicado: (2020)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Martín-Galiano, Antonio J., et al.
Publicado: (2021)

Protective neutralizing epitopes in SARS‐CoV‐2
por: Liu, Hejun, et al.
Publicado: (2022)

Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2
por: Hevesi, Zsofia, et al.
Publicado: (2022)

Development of multi-epitope peptide-based vaccines against SARS-CoV-2
por: Lim, Hui Xuan, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition
por: Hattori, Takamitsu, et al.
Publicado: (2020)

Designing a multi-epitope peptide based vaccine against SARS-CoV-2
por: Singh, Abhishek, et al.
Publicado: (2020)

Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2
por: Banerjee, Souvik, et al.
Publicado: (2020)

Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
por: Chen, Hong-Zhi, et al.
Publicado: (2020)

Evaluation of vaccine effectiveness against SARS‐CoV‐2 variants by serological epitope profiling
por: Li, Cheng, et al.
Publicado: (2023)

An overview of preclinical animal models for SARS-CoV-2 pathogenicity
por: Munshi, Itti, et al.
Publicado: (2021)

A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
por: Pardieck, Iris N., et al.
Publicado: (2022)

Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2
por: Li, Lili, et al.
Publicado: (2022)

Epitope Identification and Designing a Potent Multi-epitope Vaccine Construct against SARS-CoV-2 Including the Emerging Variants
por: Srinivasan, Sivasubramanian, et al.
Publicado: (2022)

Variable susceptibility of intestinal organoid–derived monolayers to SARS-CoV-2 infection
por: Jang, Kyung Ku, et al.
Publicado: (2022)

Landscape and Selection of Vaccine Epitopes in SARS-CoV-2
por: Smith, Christof C., et al.
Publicado: (2020)

Landscape and selection of vaccine epitopes in SARS-CoV-2
por: Smith, Christof C., et al.
Publicado: (2021)

Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models
por: Banihashemi, Seyed Reza, et al.
Publicado: (2022)

Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants
por: Fan, Shengtao, et al.
Publicado: (2022)

A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice
por: Cao, Kangli, et al.
Publicado: (2022)

Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2)
por: Sarkar, Bishajit, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j13ok5qk33v0qbrvlktm03cpbe